Cited 3 times in

Pharmacokinetics

DC Field Value Language
dc.contributor.author변석호-
dc.date.accessioned2015-04-24T16:58:39Z-
dc.date.available2015-04-24T16:58:39Z-
dc.date.issued2009-
dc.identifier.issn0161-6420-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/104527-
dc.description.statementOfResponsibilityopen-
dc.relation.isPartOfOPHTHALMOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAngiogenesis Inhibitors/pharmacokinetics*-
dc.subject.MESHAnimals-
dc.subject.MESHAntibodies, Monoclonal/pharmacokinetics*-
dc.subject.MESHAntibodies, Monoclonal, Humanized-
dc.subject.MESHAqueous Humor/metabolism*-
dc.subject.MESHBevacizumab-
dc.subject.MESHBiological Availability-
dc.subject.MESHHalf-Life-
dc.subject.MESHModels, Biological-
dc.subject.MESHRabbits-
dc.subject.MESHRanibizumab-
dc.subject.MESHTissue Distribution-
dc.subject.MESHVascular Endothelial Growth Factor A/antagonists & inhibitors-
dc.subject.MESHVitreous Body/metabolism*-
dc.titlePharmacokinetics-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Ophthalmology (안과학)-
dc.contributor.googleauthorLOUIS TONG-
dc.contributor.googleauthorTIEN Y. WONG-
dc.identifier.doi10.1016/j.ophtha.2008.09.016-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA01849-
dc.relation.journalcodeJ02432-
dc.identifier.eissn1549-4713-
dc.identifier.pmid19118710-
dc.identifier.urlhttp://www.sciencedirect.com/science/article/pii/S0161642008009044-
dc.contributor.alternativeNameByeon, Suk Ho-
dc.contributor.affiliatedAuthorByeon, Suk Ho-
dc.citation.volume116-
dc.citation.number1-
dc.citation.startPage168-
dc.citation.endPage169-
dc.identifier.bibliographicCitationOPHTHALMOLOGY, Vol.116(1) : 168-169, 2009-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Ophthalmology (안과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.